HBI
58
2
CNP
52
-2
MSI
55
-2
F
42
2
KIM
58
-2
MPC
33
2
EOG
30
-2
GT
49
2
CMA
48
2
QCOM
57
-2
BIIB
42
2
PVH
59
-3
LRCX
61
2
AES
49
-2
HCP
54
-2
CHD
39
2
NWSA
71
-4
XRX
57
-2
TGNA
53
3
ICE
57
2
HBI
58
2
CNP
52
-2
MSI
55
-2
F
42
2
KIM
58
-2
MPC
33
2
EOG
30
-2
GT
49
2
CMA
48
2
QCOM
57
-2
BIIB
42
2
PVH
59
-3
LRCX
61
2
AES
49
-2
HCP
54
-2
CHD
39
2
NWSA
71
-4
XRX
57
-2
TGNA
53
3
ICE
57
2
Financhill
Back

Nuveen Dow 30sm Dynamic Overwrite Fund Vs. Aligos Therapeutics Industry Stock Comparison

Sell
48

DIAX
Nuveen Dow 30sm Dynamic Overwrite Fund

Last Price:
$15.17
Seasonality Move:
-1.4%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
48
Nuveen Dow 30sm Dynamic Overwrite Fund (DIAX) is a Sell

Is Nuveen Dow 30sm Dynamic Overwrite Fund a Buy, Sell or Hold?

  • The current Nuveen Dow 30sm Dynamic Overwrite Fund [DIAX] share price is $15.34. The Score for DIAX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • DIAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DIAX Stock Price Chart

What is Nuveen Dow 30sm Dynamic Overwrite Fund's stock price today?

  • The Nuveen Dow 30sm Dynamic Overwrite Fund share price today is $15.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DIAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

DIAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 52.98 Buy
Chaikin Money Flow: 68768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.06 - 15.76) Sell
Bollinger Bands (100): (14.42 - 15.36) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

DIAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.99 Buy
20-day SMA: 15.39 Sell
50-day SMA: 15.21 Buy
200-day SMA: 14.49 Buy
8-day EMA: 15.13 Buy
20-day EMA: 15.24 Buy
50-day EMA: 15.18 Buy
200-day EMA: 14.68 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

Nuveen Dow 30sm Dynamic Overwrite Fund Earnings Growth & DIAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Nuveen Dow 30sm Dynamic Overwrite Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):